| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0003 |